What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Major depressive disorder
Siegfried Kasper focuses on Internal medicine, Psychiatry, Endocrinology, Antidepressant and Depression.
His Internal medicine research includes themes of Placebo, Light therapy, Agomelatine and Atypical antipsychotic.
His Psychiatry study combines topics in areas such as Evidence-based medicine and MEDLINE.
His studies deal with areas such as Genotype and Serotonin as well as Endocrinology.
His research in Antidepressant focuses on subjects like Pharmacology, which are connected to Clozapine.
His Depression research includes elements of Morning and Hypericum perforatum.
His most cited work include:
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (664 citations)
- Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland. (528 citations)
- The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders (413 citations)
What are the main themes of his work throughout his whole career to date?
Siegfried Kasper mostly deals with Psychiatry, Internal medicine, Depression, Endocrinology and Antidepressant.
His Psychiatry study frequently links to adjacent areas such as Clinical psychology.
Siegfried Kasper has included themes like Placebo and Treatment-resistant depression in his Internal medicine study.
His research on Placebo frequently links to adjacent areas such as Randomized controlled trial.
He is interested in Light therapy, which is a branch of Depression.
He has researched Antidepressant in several fields, including Anesthesia and Pharmacology.
He most often published in these fields:
- Psychiatry (35.35%)
- Internal medicine (27.87%)
- Depression (20.59%)
What were the highlights of his more recent work (between 2015-2021)?
- Psychiatry (35.35%)
- Internal medicine (27.87%)
- Major depressive disorder (11.32%)
In recent papers he was focusing on the following fields of study:
Siegfried Kasper mainly investigates Psychiatry, Internal medicine, Major depressive disorder, Depression and Neuroscience.
His Psychiatry study incorporates themes from Clinical trial, Randomized controlled trial and MEDLINE.
His study in Internal medicine is interdisciplinary in nature, drawing from both Placebo, Endocrinology and Oncology.
Siegfried Kasper focuses mostly in the field of Major depressive disorder, narrowing it down to matters related to Clinical psychology and, in some cases, Anxiety.
Siegfried Kasper regularly links together related areas like Rating scale in his Depression studies.
Siegfried Kasper works mostly in the field of Neuroscience, limiting it down to topics relating to Serotonergic and, in certain cases, Serotonin transporter, as a part of the same area of interest.
Between 2015 and 2021, his most popular works were:
- Serotonin and neuroplasticity - Links between molecular, functional and structural pathophysiology in depression. (119 citations)
- Assessment and management of agitation in psychiatry: Expert consensus (108 citations)
- Updated European Consensus Statement on Diagnosis and Treatment of Adult ADHD (98 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Psychiatry
His scientific interests lie mostly in Psychiatry, Internal medicine, Major depressive disorder, Depression and Treatment-resistant depression.
His Psychiatry research integrates issues from Clinical trial and Intensive care medicine.
His work deals with themes such as Endocrinology and Drug, which intersect with Internal medicine.
His study looks at the intersection of Endocrinology and topics like Serotonin transporter with Binding potential.
His Major depressive disorder research is multidisciplinary, incorporating perspectives in Antidepressant, Escitalopram, Oncology and Clinical psychology.
His Depression study combines topics in areas such as Prevalence, Comorbidity, Antipsychotic and Rating scale.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
